<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="82240">
  <stage>Registered</stage>
  <submitdate>27/08/2007</submitdate>
  <approvaldate>10/09/2007</approvaldate>
  <actrnumber>ACTRN12607000452493</actrnumber>
  <trial_identification>
    <studytitle>Prostate Cancer:The early detection and early diagnosis of Prostate Cancer</studytitle>
    <scientifictitle>The objective of the clinical trial is to compare findings achieved by traditional diagnostic procedures with those of the Medex Test in order to define specificity and accuracy of the Medex Test device as a diagnostic tool for early Prostate Cancer detection.</scientifictitle>
    <utrn />
    <trialacronym />
  </trial_identification>
  <conditions>
    <healthcondition>Prostate Cancer</healthcondition>
    <conditioncode>
      <conditioncode1>Cancer</conditioncode1>
      <conditioncode2>Prostate</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>The Medex Test device is a non-invasive and radiation free diagnostic tool. It is used for the assessment of functional abnormalities of the Prostate by electronic evaluation of the dermal-visceral connections. The principle of the Medex Test is based on detecting the change in the electrical impedance of certain dermal-visceral zones (DVZs) due to the organs disease. The Medex Test take around 20 minutes to conduct and the duration of the trial period is one year.</interventions>
    <comparator>Prostate Cancer Patients
Prostate-specific Antigen (PSA) blood test.
Digital Rectal Exam (DRE)</comparator>
    <control>Active</control>
    <interventioncode>Early detection / Screening</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>The primary objective is to evaluate the sensitivity, specificity and total accuracy of the device, through its ability to accurately and effectively diagnose Prostate Cancer.</outcome>
      <timepoint>Before traditional diagnostic method</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>The secondary objective is to evaluate technical intra-device variability between Medex Test devices.</outcome>
      <timepoint>After traditional diagnostic method</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>200 male patients with clinical symptoms of Prostate cancer and other related disorders.</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>-2147483648</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Males</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>1.Amputees 2. Females 3.Local skin damage in areas of Medex Test examination. (i.e. hands and feet)</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Diagnosis</purpose>
    <allocation>Non-randomised trial</allocation>
    <concealment />
    <sequence />
    <masking />
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>3/09/2007</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>200</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Terminated</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>St Vincent's Hospital</primarysponsorname>
    <primarysponsoraddress>406 Victoria St
Darlinghurst, NSW 2010</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>St Vincent's Hospital</fundingname>
      <fundingaddress>406 Victoria St
Darlinghurst, NSW 2010</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary />
    <trialwebsite />
    <publication />
    <ethicsreview>Not yet submitted</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>St Vincent's Hospital Human Research Ethics Committee (EC00140)</ethicname>
      <ethicaddress>406 Victoria St
Darlinghurst, NSW 2010</ethicaddress>
      <ethicapprovaldate />
      <hrec>07/SVH/27</hrec>
      <ethicsubmitdate>15/08/2007</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>David Dalley</name>
      <address>Level 4
Xavier Building
390 Victoria Street
Darlinghurst NSW 2010</address>
      <phone>+61 2 83823379</phone>
      <fax />
      <email>d.dalley@stvincents.org.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Sandra Lazarus</name>
      <address>Level 4
Xavier Building
390 Victoria Street
Darlinghurst NSW 2010</address>
      <phone>+61 2 83823379</phone>
      <fax />
      <email>s_lazarus_@hotmail.com</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>